Acute megakaryoblastic leukemia overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 9: Line 9:
This rare subtype of AML was first reported in 1931 by Von Boros and his colleagues.<ref name="OkiKantarjian2006">{{cite journal|last1=Oki|first1=Yasuhiro|last2=Kantarjian|first2=Hagop M.|last3=Zhou|first3=Xian|last4=Cortes|first4=Jorge|last5=Faderl|first5=Stefan|last6=Verstovsek|first6=Srdan|last7=O'Brien|first7=Susan|last8=Koller|first8=Charles|last9=Beran|first9=Miloslav|last10=Bekele|first10=B. Nebiyou|last11=Pierce|first11=Sherry|last12=Thomas|first12=Deborah|last13=Ravandi|first13=Farhad|last14=Wierda|first14=William G.|last15=Giles|first15=Francis|last16=Ferrajoli|first16=Alessandra|last17=Jabbour|first17=Elias|last18=Keating|first18=Michael J.|last19=Bueso-Ramos|first19=Carlos E.|last20=Estey|first20=Elihu|last21=Garcia-Manero|first21=Guillermo|title=Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center|journal=Blood|volume=107|issue=3|year=2006|pages=880–884|issn=0006-4971|doi=10.1182/blood-2005-06-2450}}</ref>
This rare subtype of AML was first reported in 1931 by Von Boros and his colleagues.<ref name="OkiKantarjian2006">{{cite journal|last1=Oki|first1=Yasuhiro|last2=Kantarjian|first2=Hagop M.|last3=Zhou|first3=Xian|last4=Cortes|first4=Jorge|last5=Faderl|first5=Stefan|last6=Verstovsek|first6=Srdan|last7=O'Brien|first7=Susan|last8=Koller|first8=Charles|last9=Beran|first9=Miloslav|last10=Bekele|first10=B. Nebiyou|last11=Pierce|first11=Sherry|last12=Thomas|first12=Deborah|last13=Ravandi|first13=Farhad|last14=Wierda|first14=William G.|last15=Giles|first15=Francis|last16=Ferrajoli|first16=Alessandra|last17=Jabbour|first17=Elias|last18=Keating|first18=Michael J.|last19=Bueso-Ramos|first19=Carlos E.|last20=Estey|first20=Elihu|last21=Garcia-Manero|first21=Guillermo|title=Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center|journal=Blood|volume=107|issue=3|year=2006|pages=880–884|issn=0006-4971|doi=10.1182/blood-2005-06-2450}}</ref>


It is classified under [[Acute_myelogenous_leukemia#French-American-British_classification|M7]] in the [[French-American-British classification]].<ref name="Bennett1985">{{cite journal|last1=Bennett|first1=John M.|title=Criteria for the Diagnosis of Acute Leukemia of Megakaryocyte Lineage (M7)|journal=Annals of Internal Medicine|volume=103|issue=3|year=1985|pages=460|issn=0003-4819|doi=10.7326/0003-4819-103-3-460}}</ref>
It is classified under [[Acute_myelogenous_leukemia#French-American-British_classification|M7]] in the [[French-American-British classification]].<ref name="Bennett1985">{{cite journal|last1=Bennett|first1=John M.|title=Criteria for the Diagnosis of Acute Leukemia of Megakaryocyte Lineage (M7)|journal=Annals of Internal Medicine|volume=103|issue=3|year=1985|pages=460|issn=0003-4819|doi=10.7326/0003-4819-103-3-460}}</ref> Subsequently, it was introduced in the WHO 2008 classification of myeloid neoplasms and acute leukemia.<ref name="VardimanThiele2009">{{cite journal|last1=Vardiman|first1=James W.|last2=Thiele|first2=Jüergen|last3=Arber|first3=Daniel A.|last4=Brunning|first4=Richard D.|last5=Borowitz|first5=Michael J.|last6=Porwit|first6=Anna|last7=Harris|first7=Nancy Lee|last8=Le Beau|first8=Michelle M.|last9=Hellström-Lindberg|first9=Eva|last10=Tefferi|first10=Ayalew|last11=Bloomfield|first11=Clara D.|title=The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes|journal=Blood|volume=114|issue=5|year=2009|pages=937–951|issn=0006-4971|doi=10.1182/blood-2009-03-209262}}</ref>


In the first three years of life megakaryoblastic leukemia is the most common type of leukemia in patients with Downs syndrome.<ref>Hitzler JK. (2007) Acute megakaryoblastic leukemia in Down syndrome. Pediatr Blood Cancer. Dec;49(7 Suppl):1066-9. PMID: 17943965. </ref>
In the first three years of life megakaryoblastic leukemia is the most common type of leukemia in patients with Downs syndrome.<ref>Hitzler JK. (2007) Acute megakaryoblastic leukemia in Down syndrome. Pediatr Blood Cancer. Dec;49(7 Suppl):1066-9. PMID: 17943965. </ref>

Revision as of 20:03, 16 April 2021

Acute megakaryoblastic leukemia Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute megakaryoblastic leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute megakaryoblastic leukemia overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute megakaryoblastic leukemia overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute megakaryoblastic leukemia overview

CDC on Acute megakaryoblastic leukemia overview

Acute megakaryoblastic leukemia overview in the news

Blogs on Acute megakaryoblastic leukemia overview

Directions to Hospitals Treating Acute megakaryoblastic leukemia

Risk calculators and risk factors for Acute megakaryoblastic leukemia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Acute megakaryoblastic leukemia (AMKL) is a form of leukemia where a majority of the blasts are megakaryoblastic.[1]

This rare subtype of AML was first reported in 1931 by Von Boros and his colleagues.[2]

It is classified under M7 in the French-American-British classification.[3] Subsequently, it was introduced in the WHO 2008 classification of myeloid neoplasms and acute leukemia.[4]

In the first three years of life megakaryoblastic leukemia is the most common type of leukemia in patients with Downs syndrome.[5]

References

  1. "Final Diagnosis -- Case 439". Retrieved 2008-03-08.
  2. Oki, Yasuhiro; Kantarjian, Hagop M.; Zhou, Xian; Cortes, Jorge; Faderl, Stefan; Verstovsek, Srdan; O'Brien, Susan; Koller, Charles; Beran, Miloslav; Bekele, B. Nebiyou; Pierce, Sherry; Thomas, Deborah; Ravandi, Farhad; Wierda, William G.; Giles, Francis; Ferrajoli, Alessandra; Jabbour, Elias; Keating, Michael J.; Bueso-Ramos, Carlos E.; Estey, Elihu; Garcia-Manero, Guillermo (2006). "Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center". Blood. 107 (3): 880–884. doi:10.1182/blood-2005-06-2450. ISSN 0006-4971.
  3. Bennett, John M. (1985). "Criteria for the Diagnosis of Acute Leukemia of Megakaryocyte Lineage (M7)". Annals of Internal Medicine. 103 (3): 460. doi:10.7326/0003-4819-103-3-460. ISSN 0003-4819.
  4. Vardiman, James W.; Thiele, Jüergen; Arber, Daniel A.; Brunning, Richard D.; Borowitz, Michael J.; Porwit, Anna; Harris, Nancy Lee; Le Beau, Michelle M.; Hellström-Lindberg, Eva; Tefferi, Ayalew; Bloomfield, Clara D. (2009). "The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes". Blood. 114 (5): 937–951. doi:10.1182/blood-2009-03-209262. ISSN 0006-4971.
  5. Hitzler JK. (2007) Acute megakaryoblastic leukemia in Down syndrome. Pediatr Blood Cancer. Dec;49(7 Suppl):1066-9. PMID: 17943965.

Template:WH Template:WS